RANKL inhibitors (Agricultural University of Athens/University of Thessaly/University of Nicosia/proACTINA)

N/A

Report date: 2025/03/20 10:01:17
NME

Base Information

Drug NameRANKL inhibitors (Agricultural University of Athens/University of Thessaly/University of Nicosia/proACTINA)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsBone metastasesOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGreeceCyprus
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgricultural University Of Athens
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of NicosiaUniversity Of ThessalyAgricultural University Of Athens +[4] 
Inactive CompaniesN/A
Active IndicationsBone metastasesOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A